Morgan Stanley downgraded Medacta Group to Equal Weight from Overweight with a price target of CHF 113, up from CHF 106. The analyst cites valuation for the downgrade with the shares up over 50% since October.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>